Skip to content
November 4, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Unveiling a Cancer’s Deceptive Strategy: OU Researchers Discover How Tumors Co-Opt the Immune System to Fuel Growth unveiling-a-cancers-deceptive-strategy-ou-researchers-discover-how-tumors-co-opt-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unveiling a Cancer’s Deceptive Strategy: OU Researchers Discover How Tumors Co-Opt the Immune System to Fuel Growth

Evan Lee Salim September 9, 2026
Oklahoma City, OK – In a groundbreaking discovery that could redefine approaches to treating aggressive cancers, researchers...
Read More Read more about Unveiling a Cancer’s Deceptive Strategy: OU Researchers Discover How Tumors Co-Opt the Immune System to Fuel Growth
Nyxoah Launches Landmark BREATHE Study: A New Chapter in Obstructive Sleep Apnea Treatment nyxoah-launches-landmark-breathe-study-a-new-chapter-in-obstructive-sleep-apnea-treatment
  • Treatment Innovations

Nyxoah Launches Landmark BREATHE Study: A New Chapter in Obstructive Sleep Apnea Treatment

Jia Lissa September 9, 2026
In a significant milestone for medical technology and sleep medicine, Belgium-based Nyxoah has officially commenced its BREATHE...
Read More Read more about Nyxoah Launches Landmark BREATHE Study: A New Chapter in Obstructive Sleep Apnea Treatment
The Science of Silence: Why Some Never Develop Cancer and the $25 Million Quest to Uncover Biological Resistance the-science-of-silence-why-some-never-develop-cancer-and-the-25-million-quest-to-uncover-biological-resistance
  • Patient Advocacy and Support

The Science of Silence: Why Some Never Develop Cancer and the $25 Million Quest to Uncover Biological Resistance

Siti Muinah September 9, 2026
In the annals of oncology, the vast majority of research has historically focused on the "how" and...
Read More Read more about The Science of Silence: Why Some Never Develop Cancer and the $25 Million Quest to Uncover Biological Resistance
Scared and Brave: Raquel’s Breast Cancer Story and the Hope She Wants You to Hold – National Breast Cancer Foundation scared-and-brave-raquels-breast-cancer-story-and-the-hope-she-wants-you-to-hold-national-breast-cancer-foundation
  • Patient Advocacy and Support

Scared and Brave: Raquel’s Breast Cancer Story and the Hope She Wants You to Hold – National Breast Cancer Foundation

Asep Darmawan September 9, 2026
A Marathon of Resilience: Breast Cancer Survivor Shares Her Journey of Hope and the Power of Community...
Read More Read more about Scared and Brave: Raquel’s Breast Cancer Story and the Hope She Wants You to Hold – National Breast Cancer Foundation
Novartis Faces Setback as Myotonic Dystrophy Drug Fails to Meet Primary Endpoint in Pivotal Trial novartis-faces-setback-as-myotonic-dystrophy-drug-fails-to-meet-primary-endpoint-in-pivotal-trial
  • Medical Research and Clinical Trials

Novartis Faces Setback as Myotonic Dystrophy Drug Fails to Meet Primary Endpoint in Pivotal Trial

Reynand Wu September 9, 2026
Novartis’s highly anticipated delpacibart etedesiran (del-desiran), a novel therapy acquired through its substantial investment in Avidity Biosciences,...
Read More Read more about Novartis Faces Setback as Myotonic Dystrophy Drug Fails to Meet Primary Endpoint in Pivotal Trial
Novartis Faces Strategic Reckoning After High-Stakes Clinical Trial Failure novartis-faces-strategic-reckoning-after-high-stakes-clinical-trial-failure
  • Treatment Innovations

Novartis Faces Strategic Reckoning After High-Stakes Clinical Trial Failure

Sagoh September 9, 2026
In a development that has sent shockwaves through the biopharmaceutical sector, Swiss pharmaceutical giant Novartis announced this...
Read More Read more about Novartis Faces Strategic Reckoning After High-Stakes Clinical Trial Failure
Biotech Market Pulse: Roivant’s Blockbuster Potential and AstraZeneca’s Regulatory Comeback biotech-market-pulse-roivants-blockbuster-potential-and-astrazenecas-regulatory-comeback
  • Chemotherapy and Targeted Therapy

Biotech Market Pulse: Roivant’s Blockbuster Potential and AstraZeneca’s Regulatory Comeback

Reynand Wu September 9, 2026
By Delilah Alvarado Published September 8, 2026 The biotechnology landscape experienced a seismic shift this week as...
Read More Read more about Biotech Market Pulse: Roivant’s Blockbuster Potential and AstraZeneca’s Regulatory Comeback
METAvivor Announces Strategic Transition to Bloomerang for Peer-to-Peer Fundraising metavivor-announces-strategic-transition-to-bloomerang-for-peer-to-peer-fundraising
  • Metastatic Breast Cancer Research

METAvivor Announces Strategic Transition to Bloomerang for Peer-to-Peer Fundraising

Nila Kartika Wati September 9, 2026
In an effort to streamline operations and enhance the donor experience, METAvivor, the leading non-profit organization dedicated...
Read More Read more about METAvivor Announces Strategic Transition to Bloomerang for Peer-to-Peer Fundraising
The Cortisol Connection: How Strategic Yoga Can Rewire Your Stress Response the-cortisol-connection-how-strategic-yoga-can-rewire-your-stress-response
  • Integrative Oncology and Holistic Care

The Cortisol Connection: How Strategic Yoga Can Rewire Your Stress Response

Nana Wu September 9, 2026
In our hyper-connected, fast-paced modern environment, stress is rarely an acute event; for many, it has become...
Read More Read more about The Cortisol Connection: How Strategic Yoga Can Rewire Your Stress Response
Advancing the Frontier of Precision Medicine: Dr. Jennifer Lovejoy Named Vice President of Translational Health Science at HudsonAlpha advancing-the-frontier-of-precision-medicine-dr-jennifer-lovejoy-named-vice-president-of-translational-health-science-at-hudsonalpha
  • Genomics and Precision Medicine

Advancing the Frontier of Precision Medicine: Dr. Jennifer Lovejoy Named Vice President of Translational Health Science at HudsonAlpha

Jia Lissa September 9, 2026
HUNTSVILLE, Ala. — The HudsonAlpha Institute for Biotechnology, a global leader in genomics and personalized medicine, has...
Read More Read more about Advancing the Frontier of Precision Medicine: Dr. Jennifer Lovejoy Named Vice President of Translational Health Science at HudsonAlpha

Posts pagination

Previous 1 … 300 301 302 303 304 305 306 … 854 Next

Recent Posts

  • Bridging Biology and Behavior: Dr. Jennifer Lovejoy Joins HudsonAlpha to Spearhead the Future of Precision Health
  • The Desk-Bound Epidemic: A 7-Minute Solution to Office-Induced Tension
  • Beyond Survival: Johana’s Journey of Resilience, Advocacy, and Finding Home at Shanti
  • A Legacy of Reconciliation: How One Daughter Chose Presence Over the Past
  • Beyond the Bottom Line: Why Generic Manufacturers Are Pivoting from Cost to Value

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

bridging-biology-and-behavior-dr-jennifer-lovejoy-joins-hudsonalpha-to-spearhead-the-future-of-precision-health
  • Genomics and Precision Medicine

Bridging Biology and Behavior: Dr. Jennifer Lovejoy Joins HudsonAlpha to Spearhead the Future of Precision Health

Sagoh November 3, 2026
the-desk-bound-epidemic-a-7-minute-solution-to-office-induced-tension
  • Integrative Oncology and Holistic Care

The Desk-Bound Epidemic: A 7-Minute Solution to Office-Induced Tension

Reynand Wu November 3, 2026
beyond-survival-johanas-journey-of-resilience-advocacy-and-finding-home-at-shanti
  • Integrative Oncology and Holistic Care

Beyond Survival: Johana’s Journey of Resilience, Advocacy, and Finding Home at Shanti

Nila Kartika Wati November 3, 2026
a-legacy-of-reconciliation-how-one-daughter-chose-presence-over-the-past
  • Psychosocial Support and Mental Health

A Legacy of Reconciliation: How One Daughter Chose Presence Over the Past

Muslim November 3, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.